abstract |
A nicotine-containing pharmaceutical composition that comprises at least 17% cocoa powder, process for manufacturing the composition and use of the composition in therapies, such as nicotine replacement therapy, weight control therapy, treatment of Alzheimer's disease, Parkinson's disease, ulcerative colitis and/or Tourette's syndrome. |